/Sponsor / Executive Profile

Kevin Conroy

Executive

Aggregate Capital Deployment Matrix

Active/Searching: $219M (40.3%)

Professional Biography

Kevin Conroy has been a prominent figure in the corporate landscape, serving on the ARYA Board since 2018. He has held the position of Chief Executive Officer at Exact Sciences Corporation since 2009, where he has been instrumental in driving the company's strategic vision and operational success. In addition to his role at Exact Sciences, Mr. Conroy has been a member of the board of directors for various organizations, including his appointment in September 2021. His extensive experience in leadership and governance positions underscores his commitment to advancing corporate objectives and fostering innovation within the healthcare sector. As a seasoned executive, Kevin Conroy continues to contribute his expertise and insights to the boards he serves, enhancing their strategic direction and overall performance.

Total Capital Deployed

$544,300,000

Active / Searching Capital:
$219,300,000

Transaction Volume

4 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

25.0%

Professional Network Intelligence

Frequent Associates

Top Sectors

  • Biotechnology1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
RDTX
Roman DBDR Tech Acquisition Corp. II
searching
219.3M
$10.00
1/2Oct 2021--GeneralB. Riley Securities, Inc.
SLGC
CM Life Sciences II Inc.
announced
200.0M
$11.50
1/1Feb 2021-
1.3B
GeneralJefferies LLC
IMTX
Immatics N.V.
closed
-
$10.00
-Jul 2020Done
350.0M
Biotechnology
ARYA
ARYA Sciences Acquisition Corp.
closed
125.0M
$10.00
1/2Sep 2018Done
350.0M
GeneralJefferies LLC